Clinical Trial: A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors

U.S., Sept. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07806175) titled 'A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors' on Aug. 31.

Brief Summary: This study aims to evaluate the safety and efficacy of RCZY690 therapy in participants with advanced malignant solid tumors. Participants will receive RCZY690 monotherapy until the end of the study.

Study Start Date: Sept. 15

Study Type: INTERVENTIONAL

Condition: Advanced Malignant Solid Tumors

Intervention: DRUG: RCZY690 Tablets

Oral medication. The patient will continue treatment until unacceptable toxic reactions occur, the disease progresses, or any criteria for leaving the study are met.

DRUG: ...